论文部分内容阅读
目的:研究中成药丹参川芎嗪注射液在胎儿宫内生长受限FGR(fetal intrauterine growth restriction)治疗中的作用效果。方法:选取2010年1月~2012年1月在大庆龙南医院住院治疗的孕妇有胎儿宫内生长受限(FGR)的106例,其中54例作为治疗组,应用丹参川芎嗪注射液联合西药治疗,另外52例作为对照组,单纯应用西药治疗,比较分析2组治疗的有效率有无差别。结果:应用丹参川芎嗪注射液联合西药治疗组在治疗FGR的效果明显优于单纯西药治疗组(P<0.05)。结论:在FRG中使用丹参川芎嗪注射液联合西药治疗,能明显促进胎儿生长发育,治疗效果明显优于单纯西药治疗。
Objective: To study the effect of Chinese medicine Salviae miltiorrhizae ligustrazine injection in the treatment of fetal intrauterine growth restriction (FGR). Methods: From January 2010 to January 2012 in Daqing Longnan Hospital, pregnant women with intrauterine growth restriction (FGR) of 106 cases, of which 54 cases as the treatment group, the application of Salvia Ligustrazine injection combined with western medicine , Another 52 cases as a control group, the simple application of Western medicine treatment, comparative analysis of two groups of treatment efficiency is there any difference. Results: The application of Salviae miltiorrhizae ligustrazine injection combined with western medicine treatment group was significantly better than western medicine treatment group (P <0.05). Conclusion: The use of Salviae miltiorrhizae ligustrazine injection combined with western medicine in FRG can obviously promote the growth and development of the fetus, and the treatment effect is obviously better than that of western medicine alone.